CUREWELL CAPITAL MANAGEMENT, LLC
CUREWELL CAPITAL MANAGEMENT, LLC is a Series C+ fund in the US writing $50M–$500M checks into Healthcare, healthcare-tech and healthcare-services.
- Stages
- Series C+
- Sectors
- Healthcare, healthcare-tech, healthcare-services
- Check size
- $50M–$500M
- Invests in
- US-wide
- Actively investing
- Yes
- Founded
- 2021
- Assets under management
- $535M
Thesis
Curewell Capital Management, LLC is a private equity firm established in 2021, exclusively focused on the healthcare sector in the United States. The firm aims to build and scale industry-leading healthcare companies by partnering with founders and management teams. Their investment thesis centers on healthcare services, healthcare technology, and digital health companies. The firm targets growth-stage businesses with an EBITDA between $5 million and $50 million, aiming to scale established healthcare platforms and accelerate innovation. They invest in both minority and majority equity positions. Curewell Capital's proprietary GRO™ framework is utilized to drive long-term value through growth and operational excellence. The firm's geographic scope is primarily the United States, with a focus on North America. Curewell Capital closed its inaugural fund, Curewell Capital I, LP, at its hard cap of $535 million in August 2025. The firm's typical check size per investment deal ranges from $50 million to $500 million.
Common questions
Does CUREWELL CAPITAL MANAGEMENT, LLC invest at the Series C+ stage?
Yes. CUREWELL CAPITAL MANAGEMENT, LLC lists Series C+ among the stages it invests in.
What check size does CUREWELL CAPITAL MANAGEMENT, LLC write?
CUREWELL CAPITAL MANAGEMENT, LLC writes $50M–$500M checks.
Where does CUREWELL CAPITAL MANAGEMENT, LLC invest?
CUREWELL CAPITAL MANAGEMENT, LLC invests in the US.